<?xml version="1.0"?>
<Articles JournalTitle="Journal of Medical Bacteriology">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Journal of Medical Bacteriology</JournalTitle>
      <Issn>2251-8649</Issn>
      <Volume>12</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="epublish">
        <Year>2024</Year>
        <Month>01</Month>
        <Day>02</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Incidence of Clostridium difficile in Patients with Antibiotic Associated Diarrhea</title>
    <FirstPage>16</FirstPage>
    <LastPage>24</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Iswarya</FirstName>
        <LastName>P</LastName>
        <affiliation locale="en_US">Senior Resident, Amala Institute of Medical Sciences</affiliation>
      </Author>
      <Author>
        <FirstName>Chithra</FirstName>
        <LastName>Valsan</LastName>
        <affiliation locale="en_US">Head of Department &amp; Professor, Department of Microbiology, JMMC&amp;RI</affiliation>
      </Author>
      <Author>
        <FirstName>Ardra</FirstName>
        <LastName>M</LastName>
        <affiliation locale="en_US">Associate Professor, Microbiology, JMMC&amp;RI</affiliation>
      </Author>
      <Author>
        <FirstName>John</FirstName>
        <LastName>Paul</LastName>
        <affiliation locale="en_US">Associate Professor, Department of Critical Care , JMMC&amp;RI</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2023</Year>
        <Month>10</Month>
        <Day>27</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2023</Year>
        <Month>12</Month>
        <Day>13</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background: This study was performed to determine the magnitude of Clostridioides difficile
infection (CDI) in a tertiary care hospital in patients with antibiotic associated diarrhea (AAD) and to
study the risk factors associated with this disease.
Methods: A descriptive study was conducted in the department of Microbiology in a tertiary care
hospital during December 2019 to May 2021. Stool samples were collected from patients with signs
and symptoms of AAD who had been consuming antibiotic or anticancer drugs durng six weeks before
the sampling. The samples were subjected to C. difficile glutamate dehydrogenase (GDH) enzyme and
CD toxin A &amp; B detection by Enzyme Linked Fluorescent Assay (ELFA). Patient&#x2019;s demographic
features and clinical details were noted and statistically correlated with the test results.
Results: Among the total 70 samples tested 20 (28%) were positive for GDH alone and 12 (17%) were
positive for both GDH and CD toxin A and B. Fluoroquinolones was a significant risk factor in the
study. Sepsis and colitis was found to have significant association with C.difficile infection in our study.
The crude mortality rate was 17%.
Conclusion: Prompt and precise diagnosis and knowledge about the risk factors of CDI helps in
effective management and prevention of CDI.</abstract>
    <web_url>https://jmb.tums.ac.ir/index.php/jmb/article/view/499</web_url>
  </Article>
</Articles>
